Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ryssel HJ"'
Publikováno v:
Clinical Pharmacology and Therapeutics. 39:619-624
Alizapride is a new substituted benzamide with suggested superior antiemetic efficacy to and fewer side effects than metoclopramide. High-dose alizapride (4 mg/kg X five doses) was compared with high-dose metoclopramide (2 mg/kg X five doses) in a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec665ebfe01cd109faa75ead852eb73
https://doi.org/10.1038/clpt.1986.109
https://doi.org/10.1038/clpt.1986.109
Autor:
Eduard E. Holdener, Pierre Alberto, Victor Hofmann, P. Siegenthaler, Reto Abele, Susanna Kaplan, Ryssel Hj, Diethelm Hartmann, Franco Cavalli
Publikováno v:
Journal of Clinical Oncology. 1:750-754
Doxifluridine, a new fluoropyrimidine derivative, was tested in a cooperative phase II trial by the Swiss Group for Clinical Cancer Research in advanced measurable colorectal cancer. The drug was given in a five consecutive day schedule by a bolus in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7d526ddc005836720c5c634fdcf4ddd
https://doi.org/10.1200/jco.1983.1.12.750
https://doi.org/10.1200/jco.1983.1.12.750
Autor:
Urs A. Leuenberger, Aron Goldhirsch, Sonntag Rw, Franco Cavalli, Joss R, Ryssel Hj, Kurt W. Brunner
Publikováno v:
Oncology. 39:284-286
33 patients were treated with a combination of tamoxifen and fluoxymesterone (10 mg t.i.d. each) after progression on prior hormonotherapy (HT). 6 of 22 patients (27%) exhibiting a partial response (PR) or stable disease (NC) on previous HT responded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e53f3379b6e5254b6d298160eef606
https://doi.org/10.1159/000225652
https://doi.org/10.1159/000225652
Publikováno v:
Tumori. 63(2)
Thirty patients with bronchogenic carcinoma were treated with an 8–week induction therapy consisting of cyclophosphamide, methotrexate, vincristine and VP 16–213 (NSC 141 540). Those who achieved objective remission or tumor stabilization were th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d872764b8ddd7e0d4d13f2c9961883
https://pubmed.ncbi.nlm.nih.gov/898287
https://pubmed.ncbi.nlm.nih.gov/898287
Autor:
Abele R, Alberto P, Kaplan S, Siegenthaler P, Hofmann V, Ryssel HJ, Hartmann D, Holdener EE, Cavalli F, Swiss Group for Clinical Cancer Research (SAKK)
Publikováno v:
Journal of Clinical Oncology; 10/20/2008, Vol. 26 Issue 30, pc217-21, 1p
Publikováno v:
American journal of clinical oncology [Am J Clin Oncol] 1982 Oct; Vol. 5 (5), pp. 501-3.
Publikováno v:
Cancer treatment reports [Cancer Treat Rep] 1980 Feb-Mar; Vol. 64 (2-3), pp. 335-7.
Publikováno v:
Schweizerische medizinische Wochenschrift [Schweiz Med Wochenschr] 1974 Aug 17; Vol. 104 (33), pp. 1154-7.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1986 Jun; Vol. 39 (6), pp. 619-24.
Publikováno v:
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 1981 Aug 28; Vol. 106 (35), pp. 1105-9.